Hence, the significant reduction in the pruritus after JNJ39758979 administration can be concluded in the way that drug-induced agranulocytosis can be most likely an off-target effect and other H4R antagonists could be beneficial in the treatment of AD, particularly pruritus, without serious adverse effects [101]. This evidence concerns the gene HRH4 and Pruritus.